Cargando…
Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
BACKGROUND: Many patients with rheumatoid arthritis (RA) require a trial of multiple biologic disease-modifying anti-rheumatic drugs (bDMARDs) to control their disease. With the availability of several bDMARD options, the history of bDMARDs may provide an alternative approach to understanding subphe...
Autores principales: | Das, Priyam, Weisenfeld, Dana, Dahal, Kumar, De, Debsurya, Feathers, Vivi, Coblyn, Jonathan S., Weinblatt, Michael E., Shadick, Nancy A., Cai, Tianxi, Liao, Katherine P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236724/ https://www.ncbi.nlm.nih.gov/pubmed/37269020 http://dx.doi.org/10.1186/s13075-023-03072-0 |
Ejemplares similares
-
Meaning of patient global assessment when joint counts are low in rheumatoid arthritis
por: Felson, David, et al.
Publicado: (2022) -
The Role of Shared Epitope in Rheumatoid Arthritis Prognosis in Relation to Anti-Citrullinated Protein Antibody Positivity
por: Zhuo, Joe, et al.
Publicado: (2022) -
The Association Between Reduction in Inflammation and Changes in Lipoprotein Levels and HDL Cholesterol Efflux Capacity in Rheumatoid Arthritis
por: Liao, Katherine P., et al.
Publicado: (2015) -
The Impact of Exercise, Lifestyle, and Clinical Factors on Perceived Cognitive Function in Patients with Rheumatoid Arthritis: Results from a Prospective Cohort Study
por: Shadick, Nancy A., et al.
Publicado: (2019) -
Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis
por: Ercan, Altan, et al.
Publicado: (2012)